Press Releases
Skin is the body's
largest organ, covering the entire external surface. It serves as a barrier
against pathogens, ultraviolet radiation, chemical agents, and mechanical
injury, while also sensing external stimuli, regulating temperature, and
maintaining hydration. The skin is organized into three principal layers: the
epidermis, dermis, and hypodermis.
The epidermis is the
outermost layer and the body's first line of defense against the external
environment. From the surface inward, it is further subdivided into the stratum
corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum
basale. The epidermis itself is avascular, deriving nutrients from the
underlying dermis.
The dermis is the
connective tissue layer immediately beneath the epidermis, comprising a
superficial papillary layer and a deeper reticular layer that merge without a
distinct boundary. It contains hair follicles, glands, blood vessels, and nerve
endings.
The hypodermis
(subcutaneous tissue) is the deepest skin layer, anchored to the dermis by collagen
and elastin fibers. It contains adipose lobules, blood vessels, and nerves, and
serves as the body's primary fat storage depot, as well as providing insulation
and mechanical cushioning.

Figure 1.
Schematic of skin structure (PMID: 29262154)
Skin diseases
are among the most common and frequently encountered conditions in daily life,
and many follow a chronic course. Psoriasis is a chronic inflammatory
skin disease characterized by abnormal, rapid, and excessive proliferation of
the epidermal keratinocytes, manifesting as well-demarcated or widespread scaly
erythematous plaques. Acne vulgaris is another prevalent chronic
inflammatory condition arising from follicular occlusion and inflammation,
primarily presenting as papules, pustules, and scarring on the face and back;
contributing factors include androgen excess, hypersecretion of sebaceous
glands, and abnormal follicular keratinization. Vitiligo results from
the destruction of epidermal melanocytes, leading to focal melanin deficiency
and depigmented macules; its etiology involves autoimmunity, genetic
predisposition, and neurochemical factors.

Figure 2.
Pathogenesis of psoriasis (PMID: 30909615)
Research into
these skin conditions frequently requires in vivo experimentation. Recombinant
adeno-associated viral vectors (rAAV) have become an essential tool for in vivo
gene delivery, valued for their serotype diversity, low immunogenicity, and
capacity for long-term stable transgene expression — making them an ideal
platform for gene therapy in skin biology.
01 AAV Serotype
Selection
AAV serotypes
differ in their capsid proteins and, consequently, in their tropism for
specific tissues and cell types. Based on published literature, AAV2, AAV5,
AAV7, AAV8, AAV9, and AAVDJ have all been reported to transduce skin
tissue. Among these:
• AAV5
and AAV8 transduce the epidermis with high efficiency and show moderate
transduction of the dermis.
• AAV9 is
widely used for general skin transduction in vivo.
• AAVDJ mediates efficient gene delivery across skin
layers.

Figure 3.
AAV5 and AAV8 transduction of the epidermis and dermis (PMID: 22713157)

Figure 4.
Efficient skin transduction by AAVDJ (PMID: 30185909)
02 Promoter
Selection
The skin
contains a diverse array of cell types. The epidermis harbors
keratinocytes, Langerhans cells, Merkel cells, and melanocytes. Dermal
fibroblasts synthesize collagen and elastic fibers. The hypodermis
is rich in adipocytes that store energy and provide cushioning.
Cell-type-specific promoters enable precise targeting of each population.
Keratinocytes
Keratinocytes are the
predominant cell type of the epidermis, accounting for approximately 95% of
epidermal cells. They originate in the stratum basale, progressively migrate
toward the surface as they mature and differentiate, gradually flattening and
accumulating keratin, and ultimately desquamate as the stratum corneum to form
the skin's protective barrier.
• K14 (encoding
cytokeratin 14) and BK5 (encoding cytokeratin 5) are expressed specifically in
basal layer keratinocytes. Accordingly, the K14 and BK5 promoters selectively
target basal keratinocytes.
• K10 (encoding
cytokeratin 10) is expressed in suprabasal, post-mitotic keratinocytes
undergoing terminal differentiation. The K10 promoter therefore drives
expression specifically in differentiating keratinocytes above the basal layer.
Melanocytes
Melanocytes reside in the
stratum basale of the epidermis, where they synthesize melanin — the primary
pigment responsible for skin color — and protect the skin from ultraviolet
radiation. The mTyr promoter (mouse tyrosinase promoter) confers
melanocyte-specific transgene expression.

Figure 5.
Cre recombinase expression driven by the melanocyte-specific mTyr promoter
following cutaneous delivery induces melanoma formation (PMID: 31649959)
Recommended
AAV Serotypes & Promoters for Skin Targeting
|
Target |
Promoter |
Serotype |
|
Skin |
K14 / BK5 : Keratinocytes |
AAV9/AAV8/AAVDJ |
|
K10 : Keratinocytes |
||
|
mTyr : Melanocytes |
||
|
CBh/CMV/CAG/U6 : Broad infection |
Table 1.
Recommended AAV serotypes and promoters for skin-targeted gene delivery
03 Injection
Routes & Dosing
The two most
commonly used delivery methods for AAV-mediated skin gene transfer are
subcutaneous (SC) injection and intradermal (ID) injection. Dosing parameters
for each route in adult mice are summarized below.
|
Route |
Volume |
Dose |
Difference |
|
Subcutaneous
injection (SC) |
~100
μL |
1–4E+11
vg |
Injected
into the subcutaneous tissue |
|
Intradermal
injection (ID) |
~5–30
μL |
~2E+11
vg |
Injected
between the epidermis and dermis; injection depth 1–2 mm |
Table 2.
Injection routes and dosing guidelines for AAV-mediated skin gene delivery in
adult mice
04 Application
Case Studies
Case Study
1 — FGF10 Overexpression Protects Against UVB-Induced Skin Injury
CellProliferation, 2022 | PMID: 35851701
Ultraviolet B (UVB)
irradiation induces skin injury by inhibiting keratinocyte proliferation.
Fibroblast growth factor 10 (FGF10) is a key keratinocyte mitogen that promotes
proliferation and participates in cell cycle regulation, DNA repair, apoptosis,
development, and wound healing; however, its role in UVB-induced skin injury
had not been established. This study demonstrated that FGF10 expression is
elevated in UVB-treated skin, and that FGF10 overexpression protects against
UVB-induced skin damage by restoring epidermal thickness and enhancing
keratinocyte proliferation. Mechanistically, FGF10 was found to attenuate
UVB-mediated suppression of YAP activity, thereby sustaining keratinocyte
proliferation. Using AAV-mediated FGF10 overexpression, the investigators
showed a reduction in UVB-induced epidermal thickening of the dorsal skin and
an increase in proliferating cell nuclear antigen (PCNA) density, collectively
confirming a protective role for FGF10 in UVB-induced cutaneous injury. The
AAV constructs used in this study were supplied by OBiO Tech.

|
Parameter |
Details |
|
Viral construct |
AAV9-Fgf10 |
|
Animal model |
C57BL/6 mice |
|
Injection route |
Subcutaneous injection |
|
Target tissue |
Skin |
|
Dosage |
1E+11 vg/mouse |
|
Detection time |
3 weeks |
Case Study
2 — Endothelial ACKR1 Drives Immune Cell Infiltration in Skin Fibrosis
BritishJournal of Dermatology, 2024 | PMID: 39009432
Skin fibrosis,
characterized by dermal thickening and induration, is the hallmark pathological
feature of systemic sclerosis and localized scleroderma; its etiology remains
poorly understood and effective therapies are limited. In this study,
researchers employed single-cell transcriptomics to construct a
cell-type-resolved transcriptional atlas and intercellular communication
network of fibrotic skin, providing mechanistic insight into the pathogenesis
of skin fibrosis. Their findings revealed that ACKR1 is highly expressed in
endothelial cells of fibrotic skin, where it promotes immune cell infiltration;
simultaneously, SFRP2/ASPN⁺ fibroblasts act
in concert to amplify fibrosis. Using AAV constructs produced by OBiO Tech to
suppress ACKR1 expression in a bleomycin (BLM) mouse model of skin fibrosis,
the team demonstrated a significant reduction in immune cell migration into the
dermis and attenuation of fibrosis. The AAV constructs used in this study
were produced by OBiO Tech.

|
Parameter |
Details |
|
Viral construct |
AAV-ACKR1 |
|
Animal model |
C57BL/6 mice |
|
Injection route |
Subcutaneous injection |
|
Target tissue |
Skin |
|
Dosage |
1-3E+11 vg/mouse |
|
Detection time |
7 / 21 days |
References
[2]
Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci.2019;20(6):1475.
OBiO Tech | Scientific Service |
www.obio-tech.com